Sun Pharma reports 43% rise in Q1 consolidated net profit

29 Jul 2022 Evaluate

Sun Pharmaceutical Industries has reported results for first quarter ended June 30, 2022.

The company has reported net profit at Rs 1,011.80 crore for the quarter under review as compared to net loss of Rs 138.28 crore for the same quarter in the previous year. Total income of the company increased by 33.44% at Rs 4,981.87 crore for Q1FY23 as compared Rs 3,733.30 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 42.70% in its net profit after taxes, share of profit of associates and joint venture and non-controlling interests at Rs 2,060.88 crore for the quarter under review as compared to Rs 1,444.17 crore for the same quarter in the previous year. Total income of the company increased by 9.04% at Rs 10,763.90 crore for Q1FY23 as compared Rs 9,871.26 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1608.80 -30.50 (-1.86%)
28-Jan-2026 15:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1608.80
Dr. Reddys Lab 1221.00
Cipla 1329.20
Zydus Lifesciences 896.55
Lupin 2125.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×